Why the study?
Does pre-angiography clinical and biomarker assessment identify obstructive coronary artery disease in stabilised patients with sepsis and elevated troponin?
Does pre-angiography clinical and biomarker assessment identify obstructive coronary artery disease in stabilised patients with sepsis and elevated troponin?
Answers are grounded in this paper and cite their sources.
In stabilised patients with sepsis-associated myocardial injury, conventional cardiovascular risk factors and regional wall-motion abnormalities may help guide selective coronary angiography for obstructive CAD, whereas peak hs-cTnT levels offer limited discriminatory value.
This reply refers to the comment available online at h t t p s : / / d o i . o r g / 1 0 . 1 1 8 6 / s 1 3 0 5 4 -0 2 6 -0 6 2 3 1 -2 .This reply refers to the comment available online at h t t p s : / / d o i . o r g / 1 0 . 1 1 8 6
No takes yet. Share an insight, caveat, or question.
Lörstad et al. (2026) conducted a letter in Sepsis-associated myocardial injury (n=55). Protocol coronary angiography and microvascular physiological assessment (IMR and MRR) vs. Matched cohort of patients with chronic coronary syndromes; patients without obstructive CAD vs. with obstructive CAD was evaluated on Obstructive coronary artery disease (CAD) identified on protocol coronary angiography (AUC 0.69 for number of conventional cardiovascular risk factors, 95% CI 0.55-0.83).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: